Tag: immunogenicity
Bharat Biotech Announces Phase 3 Results of COVAXIN
HYDERABAD:Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced.
Nod to Serum Institute of India for Phase 2, 3 Human Clinical Trials of Oxford Vaccine Candidate
NEW DELHI: The Drugs Controller General of India (DCGI) has given nod to the Serum.
Phase II Trial Finds Chinese COVID-19 Vaccine is Safe, Induces Immune Response
BEIJING: A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has.
Novavax Begins Clinical Trial of Covid-19 Vaccine in Australia
SYDNEY: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial.